PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pioglitazone Hydrochloride And Glimepiride, and what generic alternatives are available?
Pioglitazone Hydrochloride And Glimepiride is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE is glimepiride; pioglitazone hydrochloride. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glimepiride; pioglitazone hydrochloride profile page.
Summary for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 4 |
Clinical Trials: | 20 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE at DailyMed |
Recent Clinical Trials for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Seoul National University Hospital | Phase 4 |
Kanazawa University | Phase 4 |
Kowa Company, Ltd. | Phase 4 |
See all PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE clinical trials
Pharmacology for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
Anatomical Therapeutic Chemical (ATC) Classes for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
US Patents and Regulatory Information for PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE | glimepiride; pioglitazone hydrochloride | TABLET;ORAL | 201049-001 | Jan 4, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sandoz | PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE | glimepiride; pioglitazone hydrochloride | TABLET;ORAL | 201049-002 | Jan 4, 2013 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |